In a recent article at European Business Review, Francesc Gòdia took an in-depth look at how to scale up the production of cell culture media in a safe way. Reliability of supply, variability in performance and risk of viral infection has caused manufacturers to find new ways to develop these cell cultures. The race is on and three alternatives to traditional methods are insulin, trasferrin, and albumin. To examine the opportunities, Gòdia designed an experiment that screened for optimal compounds and another that optimized their concentration. Read the results on page 36 of the European Biopharmaceutical Review.
This March, Gaurav Chauhan, M.S., Associate Scientist II, Cell Culture and Fermentation Sciences, MedImmune, will be on hand to share the presentation A Mathematical Model: Predict How HTST Impacts Media Treatment and Resolve Scale-Up Issues at Biopharmaceutical Development and Production Week. For more information on this session and the rest of the program, download the agenda. If you'd like to join us March 30-April 2, 2015 in Huntington Beach, California, as a reader of this blog when you register to join us and mention code BDP15JPLA2, you can receive the current lowest rate available to the event!
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment